Activin-actriia antagonists and uses for promoting bone growth in cancer patients

Details for Australian Patent Application No. 2008216896 (hide)

Owner Acceleron Pharma Inc.

Inventors Knopf, John; Kumar, Ravindra; Seehra, Jasbir

Agent Shelston IP

Pub. Number AU-A-2008216896

PCT Pub. Number WO2008/100384

Priority 60/932,762 31.05.07 US; 60/900,580 09.02.07 US; 60/937,365 26.06.07 US; 61/000,528 25.10.07 US

Filing date 1 February 2008

Wipo publication date 21 August 2008

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/100384 Priority application(s): WO2008/100384

14 July 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Jun 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216902-Systems for electrical stimulation of blood vessels

2008216887-Polymer-based films and drug delivery systems made therefrom